Methods for making induced pluripotent stem cells: reprogramming à la carte (original) (raw)

• Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).
  Article CAS PubMed Google Scholar
• Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634–7638 (1981).
  Article CAS PubMed PubMed Central Google Scholar
• Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998). Princeps paper describing the generation of a human blastocyst-derived, pluripotent cell lines relevant for human transplantation medicine.
  Article CAS PubMed Google Scholar
• Hochedlinger, K. & Jaenisch, R. Nuclear reprogramming and pluripotency. Nature 441, 1061–1067 (2006).
  Article CAS PubMed Google Scholar
• Eggan, K. et al. Mice cloned from olfactory sensory neurons. Nature 428, 44–49 (2004).
  Article CAS PubMed Google Scholar
• Hochedlinger, K. & Jaenisch, R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415, 1035–1038 (2002).
  Article CAS PubMed Google Scholar
• Li, J., Greco, V., Guasch, G., Fuchs, E. & Mombaerts, P. Mice cloned from skin cells. Proc. Natl Acad. Sci. USA 104, 2738–2743 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006). The first paper describing the generation of iPSC lines from MEFs by overexpressing the Oct4, Sox2, Klf4 and Myc transcription factors.
  Article CAS PubMed Google Scholar
• Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).
  Article CAS PubMed Google Scholar
• Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49–55 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).
  Article CAS PubMed Google Scholar
• Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007).
  Article CAS PubMed Google Scholar
• Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699–702 (2008).
  Article CAS PubMed Google Scholar
• Stadtfeld, M., Brennand, K. & Hochedlinger, K. Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr. Biol. 18, 890–894 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Eminli, S., Utikal, J., Arnold, K., Jaenisch, R. & Hochedlinger, K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26, 2467–2474 (2008).
  Article CAS PubMed Google Scholar
• Kim, J. B. et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646–650 (2008).
  Article CAS PubMed Google Scholar
• Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotech. 26, 1276–1284 (2008).
  Article CAS Google Scholar
• Giorgetti, A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353–357 (2009). This paper describes the generation of iPSCs from cord blood CD133+ cells, which could facilitate the constitution of iPSC banks that represent a wide panel of relevant haplotypes that are useful for transplantation.
  Article CAS PubMed PubMed Central Google Scholar
• Loh, Y. H. et al. Generation of induced pluripotent stem cells from human blood. Blood 113, 5476–5479 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotech. 26, 101–106 (2008).
  Article CAS Google Scholar
• Wernig, M., Meissner, A., Cassady, J. P. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10–12 (2008).
  Article CAS PubMed Google Scholar
• Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
  Article CAS PubMed Google Scholar
• Daley, G. Q. et al. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4, 200–201; author reply 202 (2009).
  Article CAS PubMed Google Scholar
• Ellis, J. et al. Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell 4, 198–199; author reply 202 (2009).
  Article CAS PubMed Google Scholar
• Maherali, N. & Hochedlinger, K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595–605 (2008).
  Article CAS PubMed Google Scholar
• Kim, J. B. et al. Oct4-induced pluripotency in adult neural stem cells. Cell 136, 411–419 (2009).
  Article CAS PubMed Google Scholar
• Eminli, S. et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nature Genet. 41, 968–976 (2009). It is assumed that the level of differentiation of the donor cell population may represent a barrier to reprogramming. This article directly addresses this question by testing the reprogramming potential of mouse haematopoietic cells at different stages of differentiation.
  Article CAS PubMed Google Scholar
• Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nature Biotech. 27, 743–745 (2009). The first large-scale study evaluating the safety of iPSCs fora therapeutic context, by evaluating the teratoma-forming capacity of injected iPSC-derived secondary neurospheres generated from 36 mouse iPSC lines derived in 11 different ways.
  Article CAS Google Scholar
• Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595–601 (2009). An in-depth analysis of reprogramming in mouse cells, revealing the stochastic nature of this process and showing that almost all donor cells can give rise to iPSCs after continued culture and transcription-factor expression.
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, Y. et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475–479 (2008).
  Article CAS PubMed Google Scholar
• Tsubooka, N. et al. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells 14, 683–694 (2009).
  Article CAS PubMed Google Scholar
• Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008).
  Article CAS PubMed Google Scholar
• Silva, J. et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Mallanna, S. K. & Rizzino, A. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Dev. Biol. 344, 16–25 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nature Genet. 40, 1478–1483 (2008).
  Article CAS PubMed Google Scholar
• Judson, R. L., Babiarz, J. E., Venere, M. & Blelloch, R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nature Biotech. 27, 459–461 (2009).
  Article CAS Google Scholar
• Banito, A. et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134–2139 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature 460, 1132–1135 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140–1144 (2009). The inhibition of tumour suppressor genes such as p53 greatly improves reprogramming efficiency. This observation suggests that reprogramming per secan exert selective pressure on the pool of donor cells in which this pathway is impaired.
  Article CAS PubMed PubMed Central Google Scholar
• Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136–1139 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Utikal, J. et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145–1148 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Huangfu, D. et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nature Biotech. 26, 795–797 (2008). The first of many of articles that show the ability of chemical compounds to increase reprogramming efficiency or completely replace defined factors used in reprogramming. This work opens the door to eventually generating iPSCs using only chemicals.
  Article CAS Google Scholar
• Li, W. et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992–3000 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Huangfu, D. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotech. 26, 1269–1275 (2008).
  Article CAS Google Scholar
• Feldman, N. et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nature Cell Biol. 8, 188–194 (2006).
  Article CAS PubMed Google Scholar
• Shi, Y. et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568–574 (2008).
  Article CAS PubMed Google Scholar
• Mali, P. et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28, 713–720 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Esteban, M. A. et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71–79 (2010).
  Article CAS PubMed Google Scholar
• Chung, T. L. et al. Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells. Stem Cells 28, 1848–1855 (2010).
  Article CAS PubMed Google Scholar
• Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T. & Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5, 237–241 (2009).
  Article CAS PubMed Google Scholar
• Dravid, G. et al. Defining the role of Wnt/β-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 23, 1489–1501 (2005).
  Article CAS PubMed Google Scholar
• Marson, A. et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3, 132–135 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Okada, M., Oka, M. & Yoneda, Y. Effective culture conditions for the induction of pluripotent stem cells. Biochim. Biophys. Acta 1800, 956–963 (2010).
  Article CAS PubMed Google Scholar
• Kitamura, T. et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31, 1007–1014 (2003).
  Article CAS PubMed Google Scholar
• Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
  Article CAS PubMed Google Scholar
• Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nature Protoc. 2, 3081–3089 (2007).
  Article CAS Google Scholar
• Hawley, R. G., Lieu, F. H., Fong, A. Z. & Hawley, T. S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1, 136–138 (1994).
  CAS PubMed Google Scholar
• Jahner, D. et al. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298, 623–628 (1982).
  Article CAS PubMed Google Scholar
• Stewart, C. L., Stuhlmann, H., Jahner, D. & Jaenisch, R. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc. Natl Acad. Sci. USA 79, 4098–4102 (1982).
  Article CAS PubMed PubMed Central Google Scholar
• Hotta, A. & Ellis, J. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J. Cell. Biochem. 105, 940–948 (2008).
  Article CAS PubMed Google Scholar
• Blelloch, R., Venere, M., Yen, J. & Ramalho-Santos, M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1, 245–247 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Yao, S. et al. Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol. Ther. 10, 27–36 (2004).
  Article CAS PubMed Google Scholar
• Varas, F. et al. Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions. Stem Cells 27, 300–306 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920–1923 (2007). The first demonstration of the therapeutical potential of iPSCs in a humanized sickle-cell anaemia mouse model, highlighting the need to resolve the problems relating to the use of retroviruses and oncogenes in reprogramming for human therapy.
  Article CAS PubMed Google Scholar
• Brambrink, T. et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151–159 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ryan, M. D. & Drew, J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J. 13, 928–933 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Ryan, M. D. & Flint, M. Virus-encoded proteinases of the picornavirus super-group. J. Gen. Virol. 78, 699–723 (1997).
  Article CAS PubMed Google Scholar
• Hasegawa, K., Cowan, A. B., Nakatsuji, N. & Suemori, H. Efficient multicistronic expression of a transgene in human embryonic stem cells. Stem Cells 25, 1707–1712 (2007).
  Article CAS PubMed Google Scholar
• Kaji, K. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771–775 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez-Piza, I. et al. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells 28, 36–44 (2010).
  Article CAS PubMed Google Scholar
• Carey, B. W. et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl Acad. Sci. USA 106, 157–162 (2009).
  Article CAS PubMed Google Scholar
• Sommer, C. A. et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543–549 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sommer, C. A. et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28, 64–74 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cary, L. C. et al. Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology 172, 156–169 (1989).
  Article CAS PubMed Google Scholar
• Wang, W. et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 105, 9290–9295 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lacoste, A., Berenshteyn, F. & Brivanlou, A. H. An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell 5, 332–342 (2009).
  Article CAS PubMed Google Scholar
• Fraser, M. J., Cary, L., Boonvisudhi, K. & Wang, H. G. Assay for movement of Lepidopteran transposon IFP2 in insect cells using a baculovirus genome as a target DNA. Virology 211, 397–407 (1995).
  Article CAS PubMed Google Scholar
• Fraser, M. J., Ciszczon, T., Elick, T. & Bauser, C. Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol. Biol. 5, 141–151 (1996).
  Article CAS PubMed Google Scholar
• Wilson, M. H., Coates, C. J. & George, A. L. PiggyBac transposon-mediated gene transfer in human cells. Mol. Ther. 15, 139–145 (2007).
  Article CAS PubMed Google Scholar
• Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766–770 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yusa, K., Rad, R., Takeda, J. & Bradley, A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nature Methods 6, 363–369 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sigal, S. H. et al. Evidence for a terminal differentiation process in the rat liver. Differentiation 59, 35–42 (1995).
  Article CAS PubMed Google Scholar
• Gupta, S. Hepatic polyploidy and liver growth control. Semin. Cancer Biol. 10, 161–171 (2000).
  Article CAS PubMed Google Scholar
• Zhou, W. & Freed, C. R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667–2674 (2009).
  Article CAS PubMed Google Scholar
• Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 85, 348–362 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Seki, T. et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7, 11–14 (2010).
  Article CAS PubMed Google Scholar
• Tokusumi, T. et al. Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus Res. 86, 33–38 (2002).
  Article CAS PubMed Google Scholar
• Li, H. O. et al. A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J. Virol. 74, 6564–6569 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Inoue, M. et al. Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J. Virol. 77, 3238–3246 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008).
  Article CAS PubMed Google Scholar
• González, F. et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl Acad. Sci. USA 106, 8918–8922 (2009).
  Article Google Scholar
• Jia, F. et al. A nonviral minicircle vector for deriving human iPS cells. Nature Methods 7, 197–199 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Okita, K., Hong, H., Takahashi, K. & Yamanaka, S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nature Protoc. 5, 418–428 (2010).
  Article CAS Google Scholar
• Pollack, Y., Stein, R., Razin, A. & Cedar, H. Methylation of foreign DNA sequences in eukaryotic cells. Proc . Natl Acad . Sci . USA 77, 6463–6467 (1980).
  Article CAS Google Scholar
• Yates, J., Warren, N., Reisman, D. & Sugden, B. A _cis_-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl Acad. Sci. USA 81, 3806–3810 (1984).
  Article CAS PubMed PubMed Central Google Scholar
• Yates, J. L., Warren, N. & Sugden, B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812–815 (1985).
  Article CAS PubMed Google Scholar
• Chen, Z. Y., He, C. Y., Ehrhardt, A. & Kay, M. A. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 8, 495–500 (2003).
  Article CAS PubMed Google Scholar
• Chen, Z. Y., He, C. Y. & Kay, M. A. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum. Gene Ther. 16, 126–131 (2005).
  Article CAS PubMed Google Scholar
• Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Inoue, M. et al. p53 protein transduction therapy: successful targeting and inhibition of the growth of the bladder cancer cells. Eur. Urol. 49, 161–168 (2006).
  Article CAS PubMed Google Scholar
• Michiue, H. et al. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J. Biol. Chem. 280, 8285–8289 (2005).
  Article CAS PubMed Google Scholar
• Wadia, J. S. & Dowdy, S. F. Protein transduction technology. Curr. Opin. Biotechnol. 13, 52–56 (2002).
  Article CAS PubMed Google Scholar
• Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381–384 (2009).
  Article CAS PubMed Google Scholar
• Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472–476 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Stadtfeld, M., Maherali, N., Borkent, M. & Hochedlinger, K. A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nature Methods 7, 53–55 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Feng, B., Ng, J. H., Heng, J. C. & Ng, H. H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4, 301–312 (2009).
  Article CAS PubMed Google Scholar
• Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175–181 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Boué, S., Paramonov, I., Barrero, M. J. & Izpisúa Belmonte, J. C. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate? PLoS ONE 5, e12664 (2010).
  Article PubMed PubMed Central CAS Google Scholar